Analysts expect BioNTech SE to report revenue of 522.74 M for Q4 26, against a range of 489.94 M to 555.53 M. The most recent reported quarter, Q3 26, came in at 1.46 B, a 31.7% beat against the 1.11 B consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.23 B | 197.76 M | 307.22 M | 1.78 B | 1.07 B | 136.45 M | 120.60 M | 1.46 B | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 1.34 B | 240.49 M | 181.10 M | 904.55 M | 968.87 M | 208.99 M | 192.94 M | 1.16 B | 555.53 M | 185.76 M | 163.03 M | 1.03 B | 429.48 M | 254.79 M | 301.77 M | 1.38 B | |||||||||
| Low Estimate | 1.17 B | 219.50 M | 156.46 M | 833.00 M | 898.67 M | 195.95 M | 159.72 M | 1.06 B | 489.94 M | 166.10 M | 151.27 M | 960.49 M | 399.03 M | 219.69 M | 249.14 M | 1.25 B | |||||||||
| Consensus Estimate | 1.25 B | 230.00 M | 168.78 M | 868.77 M | 933.77 M | 202.47 M | 176.33 M | 1.11 B | 522.74 M | 175.93 M | 157.15 M | 996.94 M | 414.26 M | 237.24 M | 275.46 M | 1.31 B |
Analysts expect BioNTech SE to report earnings per share of -1.80 for Q4 26, against a range of -1.95 to -1.65. The most recent reported quarter, Q3 26, came in at 1.99, a 151.9% beat against the 0.79 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.12 | -1.87 | -1.88 | -0.14 | -1.47 | -2.43 | -3.70 | 1.99 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.46 | -2.47 | -2.76 | -1.08 | -0.18 | -2.49 | -2.39 | 0.84 | -1.65 | -3.48 | -3.76 | 0.62 | -1.84 | -2.41 | -2.44 | 1.88 | |||||||||
| Low Estimate | 0.42 | -2.67 | -2.96 | -1.28 | -0.20 | -2.79 | -2.57 | 0.74 | -1.95 | -3.78 | -4.56 | 0.52 | -2.12 | -2.93 | -2.84 | 1.70 | |||||||||
| Consensus Estimate | 0.44 | -2.57 | -2.86 | -1.18 | -0.19 | -2.64 | -2.48 | 0.79 | -1.80 | -3.63 | -4.16 | 0.57 | -1.98 | -2.67 | -2.64 | 1.79 |
Pull Wall Street consensus for BioNTech SE (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BNTX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BNTX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BNTX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();